These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28962945)

  • 21. Prognostic role of tumor necrosis in patients undergoing curative resection for gastric gastrointestinal stromal tumor: a multicenter analysis of 740 cases in China.
    Liu X; Qiu H; Zhang P; Feng X; Chen T; Li Y; Tao K; Li G; Sun X; Zhou Z;
    Cancer Med; 2017 Dec; 6(12):2796-2803. PubMed ID: 29058376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exon 11 mutations, Ki67, and p16(INK4A) as predictors of prognosis in patients with GIST.
    Cerski MR; Pereira F; Matte US; Oliveira FH; Crusius FL; Waengertner LE; Osvaldt A; Fornari F; Meurer L
    Pathol Res Pract; 2011 Nov; 207(11):701-6. PubMed ID: 22024151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study on associated biomarkers influencing recurrence, metastasis and prognosis in patients with gastrointestinal stromal tumors after complete resection].
    Fang YJ; Zhang RX; Luo RZ; Ou QJ; Wan DS; Pan ZZ; Wu XJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):242-6. PubMed ID: 23536344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].
    Liang YM; Li XH; Chen W
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1041-5. PubMed ID: 18754437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Image analysis is an excellent tool for quantifying Ki-67 to predict the prognosis of gastrointestinal stromal tumor patients.
    Sugita S; Hirano H; Hatanaka Y; Fujita H; Kubo T; Kikuchi N; Ito Y; Sugawara T; Segawa K; Hisai H; Yamashita K; Nobuoka T; Matsuno Y; Hasegawa T
    Pathol Int; 2018 Jan; 68(1):7-11. PubMed ID: 29131458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does immunohistochemistry provide additional prognostic data in gastrointestinal stromal tumors?
    Demir L; Ekinci N; Erten C; Kucukzeybek Y; Alacacioglu A; Somali I; Can A; Dirican A; Bayoglu V; Akyol M; Cakalagaoglu F; Tarhan MO
    Asian Pac J Cancer Prev; 2013; 14(8):4751-8. PubMed ID: 24083738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A correlation research of Ki67 index, CT features, and risk stratification in gastrointestinal stromal tumor.
    Li H; Ren G; Cai R; Chen J; Wu X; Zhao J
    Cancer Med; 2018 Sep; 7(9):4467-4474. PubMed ID: 30123969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended resection including adjacent organs and Ki-67 labeling index are prognostic factors in patients with retroperitoneal soft tissue sarcomas.
    Morizawa Y; Miyake M; Shimada K; Hori S; Tatsumi Y; Nakai Y; Anai S; Tanaka N; Konishi N; Fujimoto K
    World J Surg Oncol; 2016 Feb; 14(1):43. PubMed ID: 26911364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Relationship between expression of cyclin D1, Ki-67 and bcl-2 and biologic behavior in CD117-positive gastrointestinal stromal tumors].
    Sun M; Zhang XY; Zou HJ; Sun YX; Li DF
    Zhonghua Bing Li Xue Za Zhi; 2005 Dec; 34(12):788-90. PubMed ID: 16545187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subgroups of patients with very large gastrointestinal stromal tumors with distinct prognoses: a multicenter study.
    Wada N; Kurokawa Y; Nishida T; Takahashi T; Toyokawa T; Kusanagi H; Hirota S; Tsujinaka T; Mori M; Doki Y
    J Surg Oncol; 2014 Feb; 109(2):67-70. PubMed ID: 24155204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate.
    Wu TJ; Lee LY; Yeh CN; Wu PY; Chao TC; Hwang TL; Jan YY; Chen MF
    BMC Gastroenterol; 2006 Oct; 6():29. PubMed ID: 17062131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression level of the mitotic checkpoint protein and G2-M cell cycle regulators and prognosis in gastrointestinal stromal tumors in the stomach.
    Fujita A; Yamamoto H; Imamura M; Nakamura N; Maehara Y; Tsuneyoshi M; Oda Y
    Virchows Arch; 2012 Feb; 460(2):163-9. PubMed ID: 22190007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gastrointestinal stromal tumors: clinicopathologic and survival evaluation in Rebagliati Hospital].
    Manrique MN; Soriano C; Yábar A; Frisancho O; Palacios AM
    Rev Gastroenterol Peru; 2012; 32(4):357-65. PubMed ID: 23307085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of standardized AgNOR analysis and Ki-67 immunostaining in gastrointestinal stromal tumors.
    Rodolico V; Martorana A; Gulotta G; Diana G; Leonardi V; Cocorullo G; Ajello F
    Anal Quant Cytol Histol; 2003 Aug; 25(4):199-209. PubMed ID: 12961826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical characteristics and prognosis analysis of 119 cases with giant gastrointestinal stromal tumor].
    Zhang P; Zeng X; Gao J; Liu W; Shuai X; Liu K; Liu X; Cai M; Cai K; Wang G; Tao K
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1290-1295. PubMed ID: 27928802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
    Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
    Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of Rab27B nuclear expression in gastrointestinal stromal tumors.
    Wang W; Ni Q; Wang H; Zhang S; Zhu H
    Dis Markers; 2014; 2014():942181. PubMed ID: 25382899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy.
    Ács B; Zámbó V; Vízkeleti L; Szász AM; Madaras L; Szentmártoni G; Tőkés T; Molnár BÁ; Molnár IA; Vári-Kakas S; Kulka J; Tőkés AM
    Diagn Pathol; 2017 Feb; 12(1):20. PubMed ID: 28222768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of promyelocytic leukemia expression in gastrointestinal stromal tumor; integrated proteomic and transcriptomic analysis.
    Ichikawa H; Yoshida A; Kanda T; Kosugi S; Ishikawa T; Hanyu T; Taguchi T; Sakumoto M; Katai H; Kawai A; Wakai T; Kondo T
    Cancer Sci; 2015 Jan; 106(1):115-24. PubMed ID: 25457157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A multicentre retrospective cohort study of patients with gastrointestinal stromal tumors in Shandong Province].
    Ning L; Yan W; Zhang M; Gong H; Dai Y; Jiang L; Lin H; Zhang D; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):326-30. PubMed ID: 24760638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.